Overview of FDA’s Expanded Access Program for Investigational Drugs

類似資料

• Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA’s Role in Ensuring Patient Safety
  著者:: Jarow, Jonathan P., 等
  出版事項: (2017)
• Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?
  著者:: Holbein, M. E. Blair, 等
  出版事項: (2015)
• Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period
  著者:: Jarow, Jonathan P., 等
  出版事項: (2016)
• Impact of Expanded Access on FDA Regulatory Action and Product Labeling
  著者:: Jarow, Jonathan P., 等
  出版事項: (2017)
• FDA’s New Authority on Drug Shortages
  著者:: Barlas, Stephen
  出版事項: (2012)